Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. [electronic resource]
Producer: 20171116Description: 153-166 p. digitalISSN:- 1558-1497
No physical items for this record
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.